logo
Select company
Select metric
$ -232.06MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
3
Sector
7
Industry
9
History
67
$ 4.49Close
$ 2.8 - $ 12.98 52-Week Range
Ticker Information

Ticker

ALMS

Company Name

ALUMIS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALUMIS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ALMS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 4.02M$ -236.08M$ -232.06M
3/31/2025$ 3.55M$ -343.35M$ -339.8M
12/31/2024$ 3.21M$ -294.23M$ -291.02M
12/31/2023$ 3.29M$ -154.99M$ -151.7M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ALUMIS INC's latest trailing twelve months (TTM) EBITDA stands at $ -151.7M.
  • Over the past 5 years, ALUMIS INC's average EBITDA has been $ -253.64M.
  • The median EBITDA for ALUMIS INC during this period was $ -261.54M
  • ALUMIS INC reached its highest EBITDA over the past 5 years at $ -151.7M.
  • The lowest EBITDA recorded by ALUMIS INC in the same timeframe $ -339.8M

ALUMIS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
BCYC : BICYCLE THERAPEUTICS PLC $ -240.81MCAPR : CAPRICOR THERAPEUTICS INC $ -68.35MVIR : VIR BIOTECHNOLOGY INC $ -533.7MFHTX : FOGHORN THERAPEUTICS INC $ -66.44MOABI : OMNIAB INC $ -46.44MTNXP : TONIX PHARMACEUTICALS HOLDING CORP $ -79.44MPRTA : PROTHENA CORP PUBLIC LTD CO $ -258.05MABUS : ARBUTUS BIOPHARMA CORP $ -53.13MZBIO : ZENAS BIOPHARMA INC $ -175.83MAUTL : AUTOLUS THERAPEUTICS PLC $ -227.48M

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA
EBITDA for ALUMIS INC is calculated as follows: EBIT [ $ -154.99M ] + DepAmor [ $ 3.29M ]
(=) EBITDA [ $ -151.7M ]

ALMS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -339.8M

Minimum

Mar 31, 2025

$ -151.7M

Maximum

Dec 31, 2023

$ -253.64M

Average

$ -261.54M

Median

EBITDA Benchmark Analysis

The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M